FDA Drug Application (091422) for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE by ACTAVIS ELIZABETH

Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Application Number091422
Product Number001
FormTABLET;SUBLINGUAL
DosageEQ 2MG BASE;EQ 0.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Active IngredientBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE



Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.